Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti-tumour necrosis factor-alpha (cA2) therapy.
暂无分享,去创建一个
M. Feldmann | F. Brennan | R. Maini | R. Maini | K. Browne | P. Green | J. Jaspar | Patricia Green